BioScrip Snags Critical Homecare For $343M
Pharmaceutical services firm BioScrip Inc. has agreed to a $343 million cash and stock deal to buy Critical Homecare Solutions Inc., a provider of home infusion and home health agency services....To view the full article, register now.
Already a subscriber? Click here to view full article